Symptomatic Neonatal Ebstein Anomaly with Preserved Antegrade Pulmonary Blood Flow: Management and Outcomes
The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70
DOI: 10.1055/s-0046-1817247 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von I. Kozyrev und 6 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
To describe outcomes in symptomatic neonates with Ebstein anomaly and preserved antegrade pulmonary blood flow.
Methods
The retrospective review of symptomatic neonatal patients with Ebstein anomaly at one center between January 2005 and December 2024. Inclusion criteria were symptomatic presentation during the neonatal period and echocardiographic confirmation of antegrade pulmonary blood flow. Primary outcomes were early and late survival.
Results
Of 34 consecutive neonates with Ebstein anomaly, 19 (56%) met the inclusion criteria. Approximately one-third (7/19) required surgical or catheter-based intervention within the first 3 months of life. Four underwent procedures to augment pulmonary blood flow (ductal stent or Blalock-Taussig shunt), two had tricuspid valve repair with concomitant anomalies, and one required an urgent Rashkind procedure followed by ductal closure. All these patients subsequently underwent tricuspid Cone repair. More than half (12/19) were managed conservatively, out of which three had cone repair (after 6 months of age), and seven did not require any intervention during follow-up. Two patients died unexpectedly in the first few weeks of life. There have been no cases of circular shunt. Median follow-up was 2.9 years (IQR: 1.8–9.8). One-year mortality was 10% (2/19), with Kaplan–Meier estimated 15-year survival of 79%.
Conclusion
In symptomatic neonates with Ebstein anomaly and preserved antegrade pulmonary blood flow, most patients can be managed medically.
Intervention
(e.g., BT-shunt or PDA stent) is necessary if pulmonary blood flow is inadequate. This highlights the importance of individualized management followed by cone-repair at an older age in stable conditions and/or further conservative follow-up if possible. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Kozyrev, I., Vergnat, M., Arenz, C., Mini, N., Bierbach, B., Suchowerskyj, P., & Asfour, B. (2026). Symptomatic Neonatal Ebstein Anomaly with Preserved Antegrade Pulmonary Blood Flow: Management and Outcomes. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817247
Vancouver
Kozyrev I, Vergnat M, Arenz C, Mini N, Bierbach B, Suchowerskyj P, et al. Symptomatic Neonatal Ebstein Anomaly with Preserved Antegrade Pulmonary Blood Flow: Management and Outcomes. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817247
BibTeX
@article{Kozyrev2026,
author = {Kozyrev, I. and Vergnat, M. and Arenz, C. and Mini, N. and Bierbach, B. and Suchowerskyj, P. and Asfour, B.},
title = {Symptomatic Neonatal Ebstein Anomaly with Preserved Antegrade Pulmonary Blood Flow: Management and Outcomes},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 01 S 01},
pages = {S1--S70},
doi = {10.1055/s-0046-1817247}
}
EUVIMED